Asimily

Asimily is an Internet of Medical Things (IoMT) risk remediation platform that delivers risk management capabilities to secure IoT devices and web-connected equipment of medical, diagnostic, life sciences, and pharmaceutical companies in the healthcare industry. The platform provides vulnerability management, forensic analysis, anomaly detection, vendor management, policy management, prevention and remediation solutions. Asimily’s built-in policy management module uses a graphical interface to search across the entire network data for indicators of compromise and risks.

Asimily’s Distributed Sniffer is an incident response and forensics tool that determines the tactics and techniques of an attacker. Asimily inventories and classifies medical devices, IoT, and connected devices, and continuously monitors them to detect, alert, and remediate anomalies from baseline device behavior and set policies in healthcare organizations. The platform generates a risk score based on exploitability, configuration, use case, and context to prioritize critical threats, and leverages a large database of connected and stand-alone medical devices and protocols to deliver actionable intelligence for remediation of vulnerabilities.

Funding and financials

In June 2022, the company secured an undisclosed amount from MemorialCare Innovation Fund, bringing the total funding raised to nearly USD 15 million. The funds were expected to be used to accelerate the development of new platform solutions, deliver new capabilities such as forensic analysis for IoT device security and risk management, and expand within the healthcare industry.

As of June 2022, Asimily grew its revenue and customers 100% YoY, secured more than 20 million IoMT devices, having deployed its platform in more than 1,800 sites across North America and analyzed more than 1,000 terabytes of data daily to protect medical devices from risks.